Spyre Therapeutics Announces Proposed Public Offering of its Common Stock

Go back to Spyre Therapeutics Announces Proposed Public Offering of its Common Stock
(NASDAQ: SYRE) Delayed: 106.65 +0.16 (0.15%)
Previous Close $106.49    52 Week High
Open $106.49    52 Week Low
Day High $107.64    P/E N/A 
Day Low $104.94    EPS
Volume 320,312